| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |